Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3) | MicrobiomeTrials← Back to trialsNCT07637734
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-06Est. Completion: 2027-08
Enrollment target: 300 participants Locations- DelRicht Research, Overland Park, Kansas, United States
- DelRicht Research, Baton Rouge, Louisiana, United States
Other microbiome trials you might be interested in
Idiopathic CD4+ LymphocytopeniaCryptococcal MeningitisWarts
Background:
* Idiopathic CD4+ lymphocytopenia (ICL) is a condition in which there is a decreased level of CD4+ lymphocy…
Bethesda, United States
Papillomavirus Infections
This study will evaluate the efficacy, immunogenicity and safety of 9-valent human papillomavirus (9vHPV; V503) vaccine …
Guilin, ChinaEst. completion Mar 31, 2028